Lepidopteran insect cells are used routinely as hosts for foreign glycoprotein expression by recombinant baculoviruses, but the precise nature of their N-glycosylation pathway remains poorly defined. These cells clearly have processing glucosidases and mannosidases that can convert precursors to Man 3 GlcNAc 2 structures and fucosyltransferases that can add fucose to the oligosaccharide core. However, their ability to extend these structures to produce complex side chains like those found in mammalian cells remains to be determined. To begin to examine this pathway at the molecular genetic level, we isolated and characterized a class II ot-mannosidase (a-mannosidase II) cDNA from Sf9, a lepidopteran insect cell line. In mammalian cells, this enzyme catalyzes the committed step in the pathway converting N-linked carbohydrates to complex forms. Degenerate primers against conserved regions in known class II a-mannosidase protein sequences were used to generate an a-mannosidase H-specific PCR product from Sf9 cell DNA. Sequence information from this product was used to isolate a partial cDNA clone, the 5' end was isolated by ligation-anchored PCR, and the full length a-mannosidase II cDNA was assembled. This cDNA contained a long open reading frame predicted to encode an 1130 amino acid protein with 37% identity to human Golgi a-mannosidase II and with a type II membrane topology, a feature of all known Golgi processing enzymes. Southern blotting indicated that a-mannosidase II is a single copy gene in Sf9 cells. Other Lepidoptera had related a-mannosidase II genes, but there was variation among different genera, and the Sf9 a-mannosidase II cDNA did not cross-hybridize with DNA from animals outside Lepidoptera. Steady-state levels of a-mannosidase II RNA were low in uninfected Sf9 cells and even lower after baculovirus infection. The in v#ro-translated Sf9 a-mannosidase II protein had the expected size and was translocated and N-glycosylated by microsomal membranes. Expression of the Sf9 a-mannosidase II cDNA in the baculovirus system produced large amounts of a protein with the expected size and swainsonine-sensitive a-mannosidase II activity towards an aryla-mannoside substrate. These results demonstrate that Sf9 cells encode and express an a-mannosidase II with properties similar to those of the mammalian enzyme.
Introduction
Lepidopteran insect cells are used widely as hosts for foreign gene expression by recombinant baculoviruses and, like bacterial expression systems, the insect cell-baculovirus system can provide high levels of foreign gene expression (Summers and Smith, 1987; Miller, 1988; O'Reilly et al., 1992) . The insect ceU-baculovirus system also has eukaryotic protein processing capabilities and, therefore, is one of the best tools currently available for foreign glycoprotein production. However, the nature of the N-glycosylation pathway in lepidopteran insect cells and, particularly, in baculovirus-infected lepidopteran insect cells, remains poorly defined.
By comparison, the N-glycosylation pathway in higher eucaryotes is well-defined (reviewed by Kornfeld and Kornfeld, 1985) . This pathway begins with the cotranslational transfer of preformed GlCjMangGlcNAcj oligosaccharides from a dolichol-linked precursor to nascent polypeptide chains on the luminal face of the endoplasmic reticulum (ER), followed by immediate trimming of glucose residues within the ER. Additional trimming of glucose residues and as many as three of the nine mannose residues can occur within the ER. As glycoproteins transit the Golgi complex, the last a-l,2-linked mannose residues are removed by 'class F ot-mannosidases, producing a Man 5 GlcNAc2 structure (Moremen et al., 1994) . Following the addition of a single GlcNAc residue by GlcNAc transferase I, two more mannose residues are removed by Golgi a-mannosidase II, a 'class II' mannosidase (Moremen et al, 1994) . This is the committed step in the synthesis of complex type oligosaccharides, which are subsequently produced by Golgi glycosyltransferases that extend the trimmed structures by adding N-acetylglucosamine, galactose, fucose, and sialic acid residues (reviewed by Komfeld and Komfeld, 1985; Paulson and Colley, 1989; Moremen et al., 1994) .
Most information on the N-glycosylation pathway in lepidopteran insect cells has come from structural studies on foreign glycoproteins expressed in baculovirus-infected cell lines or in larvae (reviewed by Jarvis and Summers, 1992; O'Reilly et al., 1992; Jarvis, 1993a) . These studies have demonstrated that lepidopteran insect cells have processing glucosidases and mannosidases which convert high mannose oligosaccharides to trimmed structures with as few as three mannose residues (pauci-mannose structures). Several lines of evidence indicate that these cells also have a fucosyltransferase that can add fucose to the core Asn-linked GlcNAc residue (Staudacher et al., 1992) , but it remains unclear whether insect cells have the ability to extend these trimmed structures, as in mammalian cells. Most structural data indicate that baculovirus-expressed glycoproteins (Kuroda et al., 1990; Chen and Bahl, 1991; Chen etal., 1991; Wathen etal, 1991; Hogeland et al., 1992; Knepper et al., 1992; Grabenhorst et al., 1993; Yeh et al., 1993; Manneberg et al., 1994; Jarvis and Finn, 1995) and native insect glycoproteins (Butters et al, 1981; Hsieh and Robbins, 1984; Ryan et al., 1985; Nagao et al., 1987; Williams et al., 1991) have only trimmed and fucosylated high mannose or D.LJarvis et at pauci-mannose oligosaccharides. However, some recent studies indicate that lepidopteran insect cell lines have GlcNAc transferase I and II activities (Altmann et al., 1993; Velardo et al., 1993) and that they can produce glycoproteins with terminal GlcNAc (Kubelka et al., 1994; Ackermann et al., 1995) , Gal (Ogonah et al., 1996) , and sialic acid (Davidson et al, 1990; Davidson and Castellino, 1991a) .
While structural biochemistry has provided much useful information on the N-glycosylation pathway in lepidopteran insect cells, this approach is limited because it is indirect and provides only a retrospective view of the processing pathway, which must be inferred from the structures of the end-products. Conclusions about the processing pathway can be complicated by degradative pathways, which might alter the product of the biosynthetic pathway and lead to misinterpretations (Licari et al., 1993; Jarvis and Finn, 1995) . Finally, conclusions based on structural data from any one glycoprotein might apply only to that glycoprotein and not to the pathway in general. An alternative approach that circumvents these problems is to use molecular genetics to isolate genes encoding glycoprotein processing enzymes. This makes it possible to study these genes, their expression, and, ultimately, the properties of the enzymes they encode. A large number of cDNAs encoding various glycoprotein processing enzymes have been cloned and characterized in other systems (reviewed by Paulson and Colley, 1989; Lowe, 1991; Joziasse, 1992; Moremen etai, 1994; Field and Wainwright, 1995) . However, except for the recent isolation of putative class I (Kerscher et al., 1995) and class II a-mannosidase (Foster et al., 1995) cDNAs from Drosophila melanogaster, this approach has not been undertaken in insect systems, and no cDNAs encoding carbohydrate processing enzymes have been isolated from Lepidoptera, the relevant hosts for the baculovirus expression system. This report describes the isolation and characterization of a cDNA encoding an a-mannosidase II with the properties of a glycoprotein processing enzyme from a lepidopteran insect cell line, Sf9, which is the most widely used host for baculovirus-mediated foreign gene expression (Vaughn, 1977; Summers and Smith, 1987) .
Results

Isolation and characterization of an a-mannosidase II cDNA from Sf9 cells
An a-mannosidase cDNA from lepidopteran insect (Sf9) cells was isolated using a degenerate oligonucleotide PCR approach (Moremen, 1989 ) based on regions of conserved amino acid sequences in two class II a-mannosidases (Moremen et al., 1994) , namely, murine Golgi a-mannosidase II (Moremen and Robbins, 1991) and the lysosomal a-mannosidase from Dictyostelium discoideum (Schatzle et al., 1992) . The oligonucleotide primers were designed as shown in Figure 1A and used in an amplification reaction widi Sf9 cell genomic DNA, as described in Materials and methods. The resulting 669 bp amplification product was identical in size to a positive control RT-PCR product derived from murine liver rnRNA (data not shown). Similar RT-PCR products were obtained using mRNA isolated from either uninfected or baculovirus-infected Sf9 cells (data not shown). The PCR product from Sf9 genomic DNA was cloned into pPCRII and sequenced, and the translation of the amplimer sequence was compared to a translation of the GenBank sequence database, as described in Material and methods. Only class II mannosidases, including murine and human a-mannosidase II (42.3% and 43.3% identity, respectively) and D .discoideum and human lysosomal a-mannosidase (29.4% and 26.1% identity, respectively), were identified by diis analysis. This suggested that the Sf9 amplimer was derived from a gene that is related to the class II mannosidases and is more similar to the Golgi processing than the lysosomal mannosidases.
The Sf9 amplimer DNA sequence was used to design exactmatch primers against the putative Sf9 a-mannosidase II coding region, and these primers were used for PCRs with total \ DNA from an unfractionated Sf9 cDNA library, as described in Materials and methods. Electrophoretic analysis of the reaction products revealed one major DNA fragment of about the same size as the RT-PCR product (data not shown). The same result was obtained with total A. DNA from an unfractionated Sf9 genomic DNA library or with the pCRII clone containing the Sf9 amplimer, but not in negative controls which lacked template DNA or contained one specific and one nonspecific primer (data not shown). These results indicated that the uninfected Sf9 cell cDNA library included a clone containing the putative Sf9 a-mannosidase II coding region, prompting us to proceed to isolate this cDNA by using a sibling selection and PCR screening approach (Moremen, 1989) . Three positive clones were isolated through sibling selection and three rounds of plaque purification, as described in Materials and methods (data not shown). The cDNA inserts were excised as Bluescript-based plasmids and mapped by restriction analysis. The largest cDNA (about 6.5 Kb) was sequenced with universal and gene-specific primers and compared to mammalian a-mannosidase U DNA sequences. This analysis revealed extensive similarities but indicated that our cDNA clone lacked the 5' end of the a-mannosidase II coding region.
The missing 5' sequence was isolated by ligation-anchored PCR ( Figure IB ; Troutt et al., 1992) . Following synthesis of single stranded cDNA from Sf9 cell mRNA with random hexamer primers, an oligonucleotide complementary to the T3 primer sequence was ligated onto the 3' end of the cDNA product. The resulting ligation-anchored cDNA was subjected to two successive rounds of PCR with the T3 primer and nested gene-specific primers to amplify the region extending upstream of the Sf9 a-mannosidase coding region ( Figure IB) . The amplification products were resolved on agarose gels and analyzed by Southern blotting with the gene-specific 5' end probe shown in Figure IB . After the second round of PCR amplification, several products were observed by ethidium bromide staining, but only two (175 and 750 bp) hybridized with the 5' end probe (data not shown). The 750 bp product was cloned into pCRQ and sequenced, and the results showed that it overlapped and extended the 5' end of the Sf9 a-mannosidase cDNA clone by an additional 681 bp. This new sequence information was used to produce a 5' RT-PCR fragment, which was ligated in-frame to a downstream restriction fragment of the cDNA clone to produce a full-length cDNA, as shown in Figure 1C .
The assembled full-length open reading frame of the Sf9 a-mannosidase II cDNA, together with 176 bp of 5' and 179 bp of 3' sequence, is shown in Figure 2 . The 3393 bp open reading frame encodes a polypeptide of 1130 amino acids with a 37% identity to murine Golgi a-mannosidase II (Moremen and Robbins, 1991) . The first in-frame ATG in the long open reading frame is preceded by a purine at the critical -3 position, suggesting that it serves as the translation initiation site (Kozak, 1983 (Kozak, , 1986 1982) revealed a potential transmembrane domain between amino acids 14 and 34 (double-underlined in Figure 2 ) and predicted a type II transmembrane topology similar to all other cloned Golgi processing hydrolases and glycosyltransferases (Paulson and Colley, 1989; Lowe, 1991; Moremen et al., 1994) . In addition, the putative Sf9 a-mannosidase protein would have seven potential N-glycosylation sites (dotted underlines in Figure 2 ).
The protein encoded by the Sf9 a-mannosidase cDNA has extensive amino acid sequence similarity to a subclass of the class II mannosidases (Moremen et al., 1994) . This subclass is typified by the mammalian Golgi glycoprotein processing enzyme, a-mannosidase II, and a recently cloned homolog, a-mannosidase II* (Misago et al., 1996;  Figure 3B ). The regions of lowest sequence similarity are localized to the NH 2 terminal 124 amino acids of the Sf9 a-mannosidase polypeptide, which encode the putative cytoplasmic tail, transmembrane domain, and 'stem region' ( Figure 3A ). These regions were previously shown to be unessential for the catalytic activity of mammalian a-mannosidase II (Moremen et al., 1991) , indicating that there would be little selective pressure to maintain their primary sequences during evolution. Surprisingly, the predicted Sf9 a-mannosidase protein is more similar to the mammalian a-mannosidase H proteins than to the putative a-mannosidase II protein encoded by a cDNA recently isolated from Drosophila (Foster et al., 1995) .
Southern blotting analysis of the Sf9 a-mannosidase II gene
Southern blotting analyses were done to examine the structure of the Sf9 a-mannosidase II gene and its relationship to a-mannosidase II genes from other insects and higher eucaryotes. Genomic DNA from several different lepidopteran insect cell lines or from a mammalian cell line were digested with HindTR ( Figure 4A ), which does not cut the Sf9 a-mannosidase II cDNA, or with PstI ( Figure 4B ), which cuts this cDNA five times, and Southern blots were probed with a nearly full-length Sf9 a-mannosidase II fragment (Xhol-Dral in Figure IB ). The Hindm digests of DNA from Sf9, Sf21, Bm, and Md cells produced single bands with similar hybridization intensities, suggesting that these cells have single copy, closely related a-mannosidase II genes. Pstl digests of DNA from these four cell lines produced identical multiple banding patterns (there were only four bands because two of the six expected Pstl fragments were too small to be retained by the gel) with similar hybridization intensities, supporting the idea that they all have closely related a-mannosidase II genes. By contrast, HindlH and Pstl digests of genomic DNA from High 5 and Ea cells produced different banding patterns and weaker hybridization signals, suggesting that the a-mannosidase II genes in these cell lines differ from the a-mannosidase II genes in the former cell lines. This conclusion was supported by the Southern blotting results obtained after digesting genomic DNA from Sf9, High 5, and Ea cells with six different enzymes ( Figure 4C ), which revealed significant differences in the restriction maps of the a-mannosidase II genes in these cell Lines. The Sf9 probe failed to hybridize with DNA from COS cells ( Figure 4A ,B), indicating that the Sf9 a-mannosidase II gene is less closely related to the a-mannosidase II genes in these mammalian cells than it is to the a-mannosidase II genes in the various lepidopteran insect cell lines. When the blots shown in Figure 4 were stripped and rehybridized under lower stringency, the hybridization signals obtained with DNA from the various lepidopteran insect cells were approximately equal, but we still detected no hybridization with COS cell DNA (data not shown).
The nearly full-length Sf9 a-mannosidase II probe also was used for low stringency hybridizations on Southern blots of HindBI ( Figure 5A ) and Pstl ( Figure 5B ) digests of genomic DNA from various insect larvae and Xenopus laevis. The results showed that the probe hybridized with DNA from two different lepidopteran insects, Heliothis virescens (tobacco budworm) and Helicoverpa zea (corn earworm), but the hybridization signal was weaker and the digestion patterns were different, when compared to the Sf9 cell controls. The Sf9 a-mannosidase II probe failed to detectably hybridize to any nonlepidopteran insect DNA, including beetle (Coleoptera), locust (Orthoptera), cockroach (Blattaria), and fruitfly (Diptera), or to frog (Xenopus) DNA. These results supported the idea that the Sf9 a-mannosidase II gene is more closely related to the a-mannosidase II genes of other lepidopteran insects than to these same genes in animals outside of the order Lepidoptera.
Transcription of the Sf9 a-mannosidase II gene
Initially, we used Northern blotting to try to examine transcription of the Sf9 a-mannosidase II gene in uninfected and baculovirus-infected Sf9 cells, but this approach failed even using 20 (xg of poly A+ RNA (data not shown), despite being able to obtain specific RT-PCR products from these RNAs. Therefore, we turned to the use of a more sensitive technique, ribonuclease protection (Lee and Costlow, 1987) , with a 431 bp antisense riboprobe consisting of 19 bp of vector sequence followed by 412 bp of sequence from the middle of the Sf9 a-mannosidase II cDNA (positions 966-1384 in Figure 2) . The results showed that RNA from mock-infected Sf9 cells protected a 412 bp fragment of the probe (Figure 6 ), indicating that the a-mannosidase II gene is expressed in these cells. The steady state levels of a-mannosidase II-specific RNA must be very low, as we were unable to detect any protection in assays with 20 \ig of total RNA (data not shown) and large amounts (20 p,g) of poly A+ RNA produced only a relatively weak signal. The signals observed with poly A+ RNA from infected cells were even weaker than the signal obtained from unin- fected cells and little, if any, protection was observed with RNA from cells infected for 48 h ( Figure 6 ). Ethidium bromide staining of the poly A+ RNA samples used for this experiment indicated that equal amounts had been loaded (data not shown), suggesting that steady state levels of Sf9 a-mannosidase II RNA are reduced by baculovirus infection.
In vitro translation and processing of the SJ9 a-mannosidase II protein
To obtain further evidence that the Sf9 a-mannosidase II open reading frame encodes a protein, a plasmid construct containing the Sf9 a-mannosidase II cDNA was Linearized, transcribed in vitro, and the resulting RNA was used for in vitro translation experiments, as described in Materials and methods. The results showed that a protein of about the expected size was produced when a rabbit reticulocyte lysate was primed with Sf9 a-mannosidase II RNA (Figure 7 ). We also observed several additional lower molecular weight proteins, which had been seen previously in translations of murine a-mannosidase II cDNA (Moremen and Robbins, 1991) , and might be explained by premature translational termination or degradation of the full-length product When translations were done in the presence of canine pancreatic microsomal membranes, a new product was observed that was larger than the largest product translated in the absence of microsomes. Unlike the smaller products, this one was not degraded by subsequent trypsin treatment but was converted to a slightly smaller form. This result indicated that the majority of the protein was oriented towards the lumen of the microsomes, where it was protected from trypsin as a result of cotranslational translocation during synthesis. In support of this conclusion, this product was completely degraded when trypsin treatments were performed in the presence of a nonionic detergent to solubilize the membranes. The larger size of the translation product prior to proteolysis also suggested that one or more of the potential Nglycosylation sites are utilized during synthesis. Together, these results indicate that the Sf9 a-mannosidase II cDNA encodes a protein with the characteristics of a type II membrane glycoprotein. 
Expression of the Sf9 a-mannosidase II protein in the baculovirus system
In vivo evidence that the Sf9 a-mannosidase II cDNA encodes a protein was obtained by using a recombinant baculovirus to express the cDNA under the control of the strong polyhedrin promoter in infected Sf9 cells. SDS-PAGE analysis of total protein lysates of Sf9 cells infected for 48 or 72 h with this recombinant virus revealed large amounts of a new protein of about the expected size, which was not detected in mock-or wild-type virus-infected lysates at any time after infection (Figure 8 ). This result, together with the kinetics of appearance and accumulation of this protein during recombinant baculovirus infection, suggested that this protein is the product of the Sf9 a-mannosidase II cDNA. Evidence that the protein encoded by the Sf9 a-mannosidase II cDNA is actually an a-mannosidase II was obtained by biochemical activity assays with p-nitrophenyl-a-D-mannopyranoside as the substrate (Figure 9 ). Extracts from Sf9 cells infected with the recombinant baculovirus clearly contained higher levels of pNP-a-mannosidase activity than extracts from wild-type virus-infected controls. The levels of a-mannosidase activity increased with increasing time of infection with the recombinant, but not the wild type virus. The putative SfManll protein accumulated in the recombinant virus-infected cells to levels that could be detected by SDS-PAGE and Coomassie blue staining of total cell lysates prepared at 48 hr postinfection. At this very late time after infection, the overexpressed protein had low specific activity. However, this was not unexpected, as previous studies have shown that production of enzymatically active secretory pathway proteins in the baculovirus system is inefficient due to adverse effects of virus infection on host cell secretory pathway function (Jarvis and Summers, 1989; Jarvis et al., 1996) . Finally, the a-mannosidase activity detected in the recombinant baculovirus-infected cell extracts was sensitive to swainsonine, a known inhibitor of class U a-mannosidases (Moremen et al., 1994) .
Discussion
Baculoviruses are used routinely as vectors for high-level foreign gene expression and, due to the eukaryotic protein processing capabilities of their hosts, the baculovirus-insect cell system is well-suited for foreign glycoprotein production (Summers and Smith, 1987; O'Reilly et al., 1992) . However, the protein glycosylation pathways of lepidopteran insect cells are poorly defined, and it remains difficult to predict the structures of carbohydrate side-chains on foreign glycoproteins produced in this system. Most of what we know about the Nglycosylation pathway in lepidopteran insect cells is derived retrospectively from biochemical studies designed to elucidate the structures of N-linked oligosaccharides from glycoproteins synthesized in these cells. The overall conclusion from most of these data is that the N-glycosylation pathway in lepidopteran insect cells, and probably all insect cells, differs from the wellcharacterized pathway in mammalian cells. Specifically, insect cells appear to be able to N-glycosylate newly synthesized proteins and convert their side-chains to trimmed and fucosylated structures, but most biochemical data suggest that they cannot further process these side-chains to produce structures with outer chain N-acetylglucosamine, galactose, and sialic acid (Butters et al, 1981; Hsieh and Robbins, 1984; Ryan et al, 1985; Nagao et al, 1987; Kuroda et al., 1990; Chen and Bahl, 1991; Chen etal., 1991; Wathen etal., 1991; Williams et al., 1991; Hogeland et al., 1992; Knepper et al., 1992; Grabenhorst et al., 1993; Yeh et al., 1993; Manneberg et al., 1994; Jarvis and Finn; 1995) . It must be recognized, however, that this model of the insect cell N-glycosylation pathway is equivocal. Lepidopteran insect cells have N-acetylglucosaminyltransferase I and II activities (Altmann et al, 1993; Velardo et al., 1993) , indicating that they can elongate trimmed high mannose structures, and it has been shown that N-linked side-chains with terminal Nacetylglucosamine (GlcNAcMan 3 GlcNAc 2 ) can be produced by these cells (Kubelka el al., 1994; Ackermann et al., 1995; Ogonah et al., 1996; Wagner et al., 1996) . It is possible that these structures are merely transient intermediates necessary for fucosylation (Altmann et al., 1993; Kubellca et al., 1994; Altmann et al, 1995) and subsequent removal of the terminal N-acetylglucosamine by an exoglycosidase could produce the fucosylated ManjGlcNAcj structures seen in many biochemical studies. In support of this model, it has been shown that certain plant storage glycoproteins are processed via a GlcNAc extension followed by a hexosaminidase cleavage (Vitale and Chrispeels, 1984) and N-acetylglucosaminidase activity has been detected in Sf9 and other lepidopteran insect cell lines (Licari et al, 1993; Altmann et al, 1995; Wagner etal, 1996) . Alternatively, if the requisite glycosyltransferases are available in insect cells, GlcNAcMan 3 GlcNAc2 could be elongated to produce complex-type structures analogous to those found in mammalian cells. This latter possibility is supported by biochemical data showing that baculovirus-infected insect cells can produce human 7-interferon with N-linked side-chains containing outer chain N-acetylglucosamine and terminal galactose (Ogonah et al, 1996) and human plasminogen with fully complex side chains containing outer chain Nacetylglucosamine, galactose, and sialic acid (Davidson et al, 1990; Davidson and Castellino, 1991a) . It has been proposed that synthesis of complex side chains could require baculovirus-induced alterations in the cellular N-glycosylation machinery, as the proportion of complex side chains on plasminogen is higher later in infection and certain processing activities are induced by baculovirus infection (Davidson and Castellino, 1991b; Davidson et al, 1991; Velardo et al., 1993; Ren et al, 1995) . However, this idea is not supported by the results of a study which showed that there was no difference in the total glycopeptide profiles of uninfected and infected Sf9 cells (Kretzschmar et al, 1994) . Perhaps only select glycoproteins, typified by human 7-interferon and plasminogen, can be converted to complex end-products due to special properties that make them unusually good substrates for processing or unusually poor substrates for degradative pathways in these cells (Licari et al, 1993; Jarvis and Finn, 1995) . Thus, our current understanding of the N-glycosylation pathway in lepidopteran insect cells seems to reflect both the value and the limitations of using a structural biochemical approach to investigate this pathway. Whereas the biochemical approach has provided a great deal of valuable information on glycoprotein biosynthesis and processing in these cells, it has been difficult to use structural data from any one model glycoprotein to infer a generalized view of the processing pathway. The biochemical approach also is complicated by the potential postsynthetic effects of exoglycosidases on the structures of glycoprotein end-products produced by these cells (Licari et al, 1993) and the uncertain effects of viral infection on cellular protein processing pathways (Jarvis and Summers, 1989; Davidson and Castellino, 1991b; Davidson etal., 1991; Velardo et al, 1993; Kretzschmar et al, 1994; Ren et al, 1995; Jarvis et al, 1996) . Overall, any attempt to use structural data from biochemical studies to elucidate the N-glycosylation pathway in the baculovirus-insect cell system must consider both biosynthetic and degradative pathways, the relative quality of individual model glycoproteins as substrates for each, and the effects of viral infection. This is a formidable task and, for this reason, we have turned to the use of molecular genetics to begin to explore the N-glycosylation pathway in this system. By using degenerate primers designed against conserved regions in known a-mannosidase II protein sequences, we successfully isolated the first lepidopteran insect cell cDNA en- coding a glycoprotein processing enzyme. We have classified this cDNA as an a-mannosidase II because of the strategy used for its isolation and because computer analysis showed that it encodes a protein which is most similar to this subgroup of the class II a-mannosidase family (Moremen et al., 1994) . Hydropathy analysis predicted that the Sf9 a-mannosidase II protein would have type II membrane topology, as predicted for all other cloned Golgi processing hydrolases and glycosyltransferases (Paulson and Colley, 1989; Lowe, 1991; Moremen et al., 1994) . A protein of the expected size was produced when the Sf9 a-mannosidase II coding region was transcribed and translated in vitro. This protein was translocated and Nglycosylated when the lysate was supplemented with microsomal membranes and protease protection experiments suggested that it had type II membrane topology. A protein of the expected size also was produced when Sf9 cells were infected with recombinant baculoviruses containing the Sf9 a-mannosidase II coding region, and finally, biochemical assays with aryl-a-mannoside showed that this protein had swainsoninesensitive a-mannosidase activity. Thus, the Sf9 a-mannosidase II cDNA clearly encodes a protein that has the hallmark characteristics of a mammalian Golgi a-mannosidase EL Lepldopteran insect a-mannosidase II cDNA might process N-linked oligosaccharides more efficiently (Davis et ai, 1993) and that Ea cells can process N-linked oligosaccharides more extensively (Ackermann et ai, 1995; Ogonah et ai, 1996) than Sf9 cells. One might speculate that differences in the processing capabilities of these cells reflect differences in the biochemical activities of their individual a-mannosidase II gene products. We are currently isolating High Five and Ea a-mannosidase II cDNAs in order to explore this possibility. It also was interesting to find that the steady state levels of Sf9 a-mannosidase II RNA were extremely low in uninfected and baculovirus-infected Sf9 cells. This supports our previous speculation (Jarvis and Finn, 1995) that limited availability of key processing enzymes, such as a-mannosidases and N-acetylglucosaminyltransferases, might impair the ability of baculovirus-infected cells to efficiently convert relinked carbohydrates to complex forms unless the glycoprotein of interest presents an unusually good substrate for these enzymes. This could explain why complex side chains have been found on only a handful of glycoproteins produced in the baculovirus-insect cell system. With the Sf9 a-mannosidase II cDNA in hand, we can begin to test this idea by manipulating expression of the a-mannosidase II cDNA and determining how glycoprotein processing is influenced. This cDNA also will facilitate further studies on the biochemical activities and cell biology of the insect a-mannosidase II gene product, providing a more direct and unequivocal view of the Nglycosylation pathway in the baculovirus-insect cell system.
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Materials and methods
Cells and cell culture
Sf9 cells are derived from the EPLB-Sf21-AE cell line, which was originally isolated from Spodoptera frugiperda (fall armyworm) ovaries (Vaughn et al., 1977) . Sf9 cells were maintained as a suspension culture at densities between 0.3 and 3.0 x 10 6 cells per ml in TNM-FH medium (Summers and Smith, 1987) supplemented with 10% (v/v) heat-inactivated fetal bovine serum (Hazelton Research Products, Lenexa, KS), 1.25 (JLg/ml amphotericin B (Sigma Chemical Co., St. Louis, MO), 25 u.g/ml gentamicin (Sigma), and 0.1% (w/v) pluronic F68 (BASF Wynandotte, Parsippany, NJ; Murhammer and Goochee, 1988). The other lepidopteran insect cell lines used in this study were maintained as adherent or semiadherent cultures at 28°C at densities between 0.1 and 1.0 x 10* cells per ml in the same medium. These additional cell lines were IPLB-Sf21-AE (Sf21), described above; BTI-Tn-5B1^ (High Five; Wickham et al.. 1992) , derived from Trichoplusia ni (cabbage looper) eggs; MdlOS (Md; Hink and Hall, 1989) , derived from Malacosoma disstria (forest tent caterpillar) hemocytes; Bm5 (Bm; Grace, 1967) , derived from Bombyx mori (silkmoth) ovaries; and BTI-EaA (Ea; Granados and Naughton, 1975) , derived from Estigmene acrea (saltmarsh caterpillar). An SV40-transformed monkey kidney cell line, COS-1 (Gluzman, 1981) , was maintained as an adherent culture at 37°C in a humidified environment of 5% CO 2 in Dulbecco's minimal essential medium (GIBCO-BRL Life Sciences, Grand Island, NY) supplemented with 10% (v/v) fetal bovine serum, 0.3% (v/v) sodium bicarbonate, and 25 u,g/ml of gentamicin sulfate.
Isolation of an SJ9 a-mannosidase II cDNA clone
Genomic DNA was isolated from Sf9 cells by a standard method (Sambrook et al., 1989) and used for PCR (Saiki et al., 1985) with degenerate oligonucleotide primers designed against conserved regions in rodent (Moremen, 1989; Moremen and Robbins, 1991) and Dictyosteliwn discoideum (Schatzle el al., 1992) class II a-mannosidase cDNAs. The sequences of these degenerate primers are shown in Figure 1A . PCRs were done in a total volume of 25 u.1 containing 10 mM Tris-HCl (pH 8.3), 50 mM KC1, 2.5 mM MgCl 2 , 0.01% (w/v) gelatin, 0.2 mM dNTPs, 1 JLM primers, 1 u,g of genomic DNA, and 2-5 U of Taq polymerase (Perkin-Elmer, Norwalk, CT). After 40 cycles of denaturation (45 s at 92°O, annealing (45 s at 45°C), and extension (3 min at 72°C) in a Perkin-Elmer thermal cycler, a final extension was done for 5 min at 72°C and the amplification products were analyzed on 1% agarose gels. A specific amplification product was recovered and cloned into a plasmid vector designed to facilitate direct cloning of PCR products (pCRU Invitrogen, San Diego, CA), and its sequence was determined by the chain termination method (Sanger et al., 1977) . Subsequently, this sequence was used to design exactmatch primers against the putative Sf9 a-mannosidase II gene, and these primers were used to screen subpopulations of an Sf9 cDNA library in XZAPII (Short et al., 1988; Stratagene, La Jolla, CA) by sibling selection and PCR, as described previously (Moremen, 1989) . Briefly, the library was split into 43 pools of 50,000 clones, each pool was amplified in E.coli, and total X DNA was prepared from 2 x 10* progeny using a commercial anti-lambdaphage immunosorbent (Lambdasorb), according to the manufacturer's instructions (Promega Corp., Madison, WI) . These DNAs were used as templates for PCRs with the exact-match primers to determine which pools included an Sf9 a-mannosidase n clone. One positive pool was split into eight subpools of 10,000 clones, each subpool was reamplified in E.coli, total X DNA was isolated, and the PCR screening process was repeated. Finally, one positive subpool, which theoretically included an Sf9 a-mannosidase II clone at a frequency of at least 1 in 10,000, was screened by plaque hybridization (Benton and Davis, 1977; Sambrook, 1989) . The hybridization probe, which was the original Sf9 a-mannosidase n PCR amplimer that had been cloned into pCRTI, was excised with EcoRI, gel-purified twice, and uniformly labeled by the random primer method (Feinberg and Vogelstein, 1983) . Positive plaques from high-density plates were taken through two additional rounds of low density plaque hybridization for further purification and screening. The cDNA inserts in two XZAPII clones that remained positive through all three rounds of screening were excised as Bluescript-based plasmid subclones by coinfection DXJarvis et al with M13R4O8 helper phage, as described previously (Short et al., 1988) . The resulting plasmids were isolated by standard alkaline lysis extraction and CsClEtBr gradient centrifugalion procedures (Sambrook et al., 1989) and used as templates to sequence the cDNA inserts with universal and gene-specific primers (Sanger et al., 1977) .
Ligation-anchored PCR and assembly of a full-length Sf9 a-mannosidase II cDNA
The 5' end of the Sf9 a-mannosidase II cDNA was isolated by using ligationanchored PCR (Troutt et al., 1992) as outlined in Figure IB . Total RNA was prepared from a log phase culture of uninfected Sf9 cells by the method of Chirgwin and coworkers (1979) and used to prepare poly A+ RNA by oligo-dT cellulose column chromatography (Aviv and Leder, 1972) . One microgram of the poly A+ RNA was used for first-strand cDNA synthesis with random hexamer primers and an RNase H-minus form of MoMuLV reverse transcriptase (Superscript H Life Technologies, Gaithersburg, MD). After reverse transcription, the RNA was digested with RNase H and the reaction mixture was diluted and desalted by ultrafiltration in a Microcon 100 filter (Amicon, Beverly, MA). The single-stranded cDNA was recovered and a 5'-phosphorylated, 3'-blocked primer complementary to the T3 primer (5'-TCCCTTTAGTGAGGGTTAATTT-NH2-3') was ligated to its 3' end with T4 RNA ligase (New England Biolabs, Beverly, MA). The resulting anchored first-strand cDNA product was used as the template for a PCR with T3 as the upstream primer and an Sf9 a-mannosidase II-specific oligonucleotide (SD1+92-in Figure IB) as the downstream primer, under the conditions described by Apte and Siebert (1993) . The amplification product was extracted with phenol-chloroform and a fraction was used as the template for a secondary PCR under the same conditions as the primary PCR with T3 as the upstream primer and a different Sf9 a-mannosidase II-specific oligonucleotide (SfManII+157-in Figure IB) as the downstream primer. The secondary products were extracted with phenol-chloroform, gel-purified on a 1% agarose gel, and a band of interest identified by Southern blotting was recovered and cloned into pCRII. Clones containing the 5' end of the putative Sf9 a-mannosidase II cDNA were identified by colony hybridization as described previously (Sambrook et al., 1989) . The hybridization probe used for both Southern blots and colony lifts was a 144 bp PCR product from the 5' end of the Sf9 a-mannosidase II partial cDNA clone (produced with primers SfManII+13+ and SfManH+157-in Figure IB) , which had been gel-purified twice and uniformly labeled by the random primer method (Feinberg and Vogelstein, 1983) . Plasmid DNA was isolated from positive clones, purified, and the inserts were sequenced by the chain termination method (Sanger et al., 1977) .
The resulting sequence information was used to design exact-match primers for amplification of the 5' end of the putative a-mannosidase II cDNA from the original Sf9 cell cDNA preparation, as diagrammed in Figure 1C . [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] Figure 1C ) was designed to incorporate a unique BglU site at position -20, with respect to the putative translational initiation site, and the 3' primer (SfManH-Al in Figure 1C ) was located downstream of a unique Xhol site. This amplification product was cloned into pCRII to produce pSfManTI-5', several independent transformants were sequenced, and the BglHXhol fragment from a representative clone was excised and gel-purified. In parallel, the Xhol-Dral fragment of the partial a-mannosidase n cDNA clone from the Sf9 library was subcloned into a modified form of pBSKS+ (pBSAK/ BS in Figure 1Q to produce pSfManII-3'. Finally, the full-length Sf9 a-mannosidase II cDNA was assembled by inserting the BglU-Xhol fragment of pSfManII-5' into Bg/11-.X/ioI-digested pSfManII-3' to produce pSfManll, as shown in Figure 1C 
Isolation and analysis of genomic DNA
A standard method (Sambrook et al., 1989) was used to isolate genomic DNA from Sf9, Sf21, High Five, Md, Ea, Bm, or COS cells. Genomic DNA from various insect larvae or Xenopus laevis was kindly provided by Dr. Jay Bradfield, Texas A&M University, Department of Entomology. Twenty micrograms of each DNA was digested with various restriction endonucleases and the digests were resolved on a 1% agarose gel. The DNA was transferred to a positively charged nylon filter (Zetaprobe; Bio-Rad Laboratories, Hercules, CA) under alkaline conditions (Southern, 1975; Reed and Mann, 1985) , and the filter was prehybridized for at least 1 h at 68°C in a buffer containing 1.5 x SSPE (15 mM NaPO_, pH 7.0; 270 mM NaCl, and 15 mM EDTA), 1% (w/v) sodium dodecyl sulfate (SDS), 0.5% (w/v) nonfat dry milk, and 150 u.g/ml of sheared salmon sperm DNA (Sigma). High stringency hybridizations were done overnight at 68°C in the same buffer with a twice gel-punfied, random primer-labeled (Feinberg and Vogelstein, 1983) , Xhol-Dral fragment of the Sf9 a-mannosidase D cDNA clone ( Figure IB) . After hybridization, the filters were washed for 15 min at room temperature with 2 x SSC plus 0.1% SDS, then with 0.5 x SSC plus 0.1% SDS, then with 0.1 x SSC plus 0.1% SDS, and finally, for 30 min with 0.1 x SSC plus 1% SDS that had been prewarmed to 50°C. For low stringency hybridizations, the hybridization temperature was reduced to 55°C and the last wash was done at room temperature. After washing, the filters were sealed in plastic bags and exposed to Kodak (Rochester, NY) X-OMAT AR film with Fisher (Pittsburgh, PA) intensifying screens for various times at -85°C.
Isolation and analysis of RNA
Sf9 cells were grown in 500 ml spinner flasks (Bellco Glass Co., NJ) to a density of 1 x 10* cells per ml and either mock-infected or infected with wild-type baculovirus (Autographa californica multicapsid nuclear polyhedrosis virus) at a multiplicity of five plaque-forming units per cell. After adsorption for 1 h at 28°C, the cells were separated from the inoculum by low speed centrifugation, gently resuspended in 500 ml of TN-MFH medium supplemented with 10% serum, antibiotics, and pluronic F68, and returned to the spinner flask. Total RNA either was extracted immediately from the mockinfected cells or was extracted 12, 24, or 48 h later from the infected cells and used to isolate poly A+ RNA, as described above. Twenty microgram samples of each mRNA preparation were analyzed by RNase protection assays (Lee and Costlow, 1987 ) using a commercial kit according to the manufacturer's instructions (Ambion, Austin TX). The riboprobe for these assays was synthesized in vitro with T7 RNA polymerase (Melton et al., 1984) and [a- 32 P]-GTP (800 Ci/mmol; DuPont NEN, Boston, MA) using a commercial kit (Ambion) according to the manufacturer's instructions. The DNA template for the transcription reactions was pSfManHABst, a derivative of pSfManll ( Figure  1C ), linearized at the Pmh site. Transcription of this template produced a 431 bp antisense RNA consisting of 19 bp from the vector followed by 412 bp beginning at the BstXl site and ending at the Pmh site of the Sf9 a-mannosidase II cDNA (positions 1384 and 966, respectively, in Figure 2 ). Protected fragments were analyzed on 5% acrylamide, 7 M urea gels, as described previously (Jarvis, 1993b) , and the gels were dried and exposed to Kodak X-OMAT AR film with intensifying screens for various times at -85°C.
In vitro translation and processing of the Sf9 a-mannosidase II cDNA.
For these experiments, the full-length Sf9 a-mannosidase II open reading frame was subcloned downstream of an SP6 promoter in the plasmid pGem7Zf+ (Promega) to produce pGemSfManH RNA was synthesized in vitro from Jffcal-linearized pGemSfMardl as described above, except SP6 RNA polymerase was used instead of T7 RNA polymerase and the [a-32 P]-GTP was replaced by nonradioactive rGTP. A portion of the in vitro transcribed RNA was used for in vitro translation reactions in a rabbit reticulocyte lysate (Promega) in the presence or absence of canine pancreatic microsomal membranes (Blobel and Dobberstein, 1975 ; Promega), as described previously (Moremen and Robbins, 1991) . Subsequently, translation reactions were treated with water, 100 u.g/ml trypsin, or trypsin plus 0.1% (v/v) Nonidet-P40 (Zilberstein et al., 1980) , as described previously (Moremen and Robbins, 1991) . The reaction products were acetone-precipitated, and the precipitates were dried, rcdissolved in protein disruption buffer (50 mM Tris-HCl, pH 6.8; 4% (w/v) SDS; 4% (v/v) B-mercaptoethanol), and heated at 65°C for 10 min. Total solubilized proteins were analyzed by SDS-PAGE using the discontinuous buffer system of Laemmli (1970) and the gels were fluorographed with Autofluor (National Diagnostics, Atlanta, GA), dried, and exposed to Kodak X-OMAT AR film at -85°C.
Baculovirus-mediated expression of the Sf9 a-mannosidase II cDNA in insect cells
A standard method was used to isolate a recombinant baculovirus containing the Sf9 a-mannosidase II cDNA (Summers and Smith, 1987; O'Reilly et al., 1992) . The intact Sf9 a-mannosidase II open reading frame was excised from pSfManll and subcloned into the baculovirus transfer vector, pVL1392 (Webb and Summers, 1990) . The resulting plasmid, in which the Sf9 a-mannosidase II cDNA was positioned downstream of the strong polyhedrin promoter, was mixed with wild type viral DNA and the mixture was used to cotransfect Sf9 cells by a modified calcium phosphate precipitation method (Summers and Smith, 1987) . Viral progeny were harvested 5 days after transfection and resolved by plaque assay in Sf9 cells, as described previously (Summers and Smith, 1987) . Recombinants were identified by their occlusion-negative plaque phenotypes and taken through two additional rounds of plaque-purification. Vims stocks were prepared and titered by plaque assay in Sf9 cells and stored frozen in the dark at -85°C (Jarvis and Garcia, 1994) . The procedures used for baculovims infections and analysis of recombinant protein biosynthesis have been described previously (Jarvis and Summers, 1989; Jarvis et al., 1991) . Briefly, Sf9 cells were seeded into 6-well plates (Coming Glass Works, Coming, NY) at a density of 1 x 10* cells per well, mock-infected or infected at a multiplicity of about 5 plaque-forming units per cell, and incubated at 28°C until 24, 36, 48, or 72 h postinfection. At these time points, the cells were gently squirted off the plastic into the medium, pelleted, 0.5 ml of protein disruption buffer was added, and the cell pellets were triturated through a 1 ml syringe equipped with a 22 ga needle. The sheared lysates were boiled for 3 min, total solubilized proteins were resolved by SDS-PAGE, as described above, and the gels were stained with Coomassie brilliant blue, destained, and photographed.
a-Mannosidase II activity assays
Sf9 cells were infected with wild-type or recombinant baculoviruses as described above and harvested by centrifugation at various times after infection, and pellets containing 1x10* cells were resuspended in 100 u.1 of assay buffer (0.1 M MES, pH 6.3; 0.5% Triton-X-100). The cell suspensions were assayed for a-mannosidase activity by mixing 25 p-I of the cell extracts with 25 u.1 of 10 mM p-nitrophenyl a-D-mannopyranoside in the presence or absence of various concentrations of swainsonine. The reaction mixtures were incubated in a microtiter plate for 1 hr at 37°C with gentle agitation, and then quenched by the addition of 200 u,l of stop solution (133 mM glycine, 67 mM NaCl, 83 mM Na 2 CO 3 ). Absorbance was measured at 410 nm on a plate reader (Dynatech model MR 5000), corrected for light scattering at 570 nm, and the corrected absorbance values were converted to nmol p-nitrophenol using a standard curve produced on the same plate reader.
Computer methods
The cDNA sequence was assembled using the sequence assembly package of Staden (1987) . The sequence of the amplimer translation was compared to the six frame translation of the GenBank nonredundant DNA sequence database (version 91) using the TFASTA subroutine of the University of Wisconsin Genetics Computer Group (GCG) software package (Program Manual for the Wisconsin Package, Version 8.1, Genetics Computer Group, Madison, WT). The pairwise sequence comparisons were performed using the Bestfit subroutine and multiple sequence alignments and dendrograms were prepared using the Pileup and Boxshade subroutines of the GCG software package.
